North America Whole Exome Sequencing Market - Industry Trends and Forecast to 2029
North America whole exome sequencing market is projected to register a substantial CAGR of 22.0% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030. Market Segmentation North America Whole Exome Sequencing Market, By Component (Whole Exome Sequencing, Second-Generation Sequencing, and Third-Generation Sequencing), Product and Services (Systems, Kits and Services), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research, and Others), End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Clinical Laboratories, and Others), Distribution Channel (Direct Trade, Retail Sales, and Others), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2030
Overview of North America Whole Exome Sequencing Market Dynamics Driver • Increase in the adoption of whole exome sequencing (WES) Restraint • Cyber security concerns in genomics Opportunity • Strategic initiative by the key market players
Market Players
Some of the key market players for the North America whole exome sequencing market are: • Beckman Coulter, Inc. • BIONEER CORPORATION • Eurofins Scientific • ExoDx (a part of Bio-Techne) • FOUNDATION MEDICINE, INC. (A subsidiary of F. Hoffmann-La Roche Ltd) • QIAGEN • GeneFirst Limited • Illumina, Inc. • Meridian • Merck KGaA • SOPHiA GENETICS • CD Genomics • Twist Bioscience • Thermo Fisher Scientific Inc. • PerkinElmer Genomics (A Subsidiary of PerkinElmer Inc.) • GeneDx, LLC • Psomagen • Integrated DNA Technologies, Inc.
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Whole Exome Sequencing (Wes) Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market Application Coverage Grid
2.8 Product Type Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Secondary Sources
2.11 Assumptions
3 Executive Summary
4 Premium Insight
4.1 Porter’s Five Forces
4.2 Pestel Analysis
4.3 Industrial Insights:
4.4 Conclusion
5 North America Whole Exome Sequencing Market: Regulations
6 Market Overview
6.1 Drivers
6.1.1 Growing Usage Of Targeted Sequencing Methods
6.1.2 Increase In The Adoption Of Next Generation Sequencing
6.1.3 Increasing Diagnostics Applications Of Whole Exome Sequencing
Table 43 Mexico Whole Exome Sequencing Market, By End User, 2021- 2030 (Usd Million)
Table 44 Mexico Whole Exome Sequencing Market, By Distribution Channel, 2021- 2030 (Usd Million)
List Of Figures
Figure 1 North America Whole Exome Sequencing (Wes) Market: Segmentation
Figure 2 North America Whole Exome Sequencing (Wes) Market: Data Triangulation
Figure 3 North America Whole Exome Sequencing (Wes) Market: Droc Analysis
Figure 4 North America Whole Exome Sequencing (Wes) Market: Regional Vs Country Market Analysis
Figure 5 North America Whole Exome Sequencing (Wes) Market: Company Research Analysis
Figure 6 North America Whole Exome Sequencing (Wes) Market: Interview Demographics
Figure 7 North America Whole Exome Sequencing (Wes) Market: Market Application Coverage Grid
Figure 8 North America Whole Exome Sequencing (Wes) Market: Dbmr Market Position Grid
Figure 9 North America Whole Exome Sequencing (Wes) Market: Segmentation
Figure 10 Increase In Use Of Wes Technology For New Scientific Applications And Increasing The Preference Of Wes Over Whole-genome Sequencing Is Its Low-cost Sequencing Capability Is Expected To Drive The North America Whole Exome Sequencing (Wes) Market In The Forecast Period Of 2023 To 2030
Figure 11 The Component Segment Is Expected To Account For The Largest Share Of The North America Whole Exome Sequencing (Wes) Market In 2023 & 2030
Figure 12 Drivers, Restraints, Opportunities And Challenges Of The North America Whole Exome Sequencing Market
Figure 13 North America Whole Exome Sequencing Market: By Component, 2022
Figure 14 North America Whole Exome Sequencing Market: By Component, 2022-2029 (Usd Million)
Figure 15 North America Whole Exome Sequencing Market: By Component, Cagr (2022-2029)
Figure 16 North America Whole Exome Sequencing Market: By Component, Lifeline Curve
Figure 17 North America Whole Exome Sequencing Market: By Product And Service, 2022
Figure 18 North America Whole Exome Sequencing Market: By Product And Service, 2023-2030 (Usd Million)
Figure 19 North America Whole Exome Sequencing Market: By Product And Service, Cagr (2023-2030)
Figure 20 North America Whole Exome Sequencing Market: By Product And Service, Lifeline Curve
Figure 21 North America Whole Exome Sequencing Market: By Application, 2022
Figure 22 North America Whole Exome Sequencing Market: By Application, 2023-2030 (Usd Million)
Figure 23 North America Whole Exome Sequencing Market: By Application, Cagr (2023-2030)
Figure 24 North America Whole Exome Sequencing Market: By Application, Lifeline Curve
Figure 25 North America Whole Exome Sequencing Market: By End User, 2022
Figure 26 North America Whole Exome Sequencing Market: By End User, 2023-2030 (Usd Million)
Figure 27 North America Whole Exome Sequencing Market: By End User, Cagr (2023-2030)
Figure 28 North America Whole Exome Sequencing Market: By End User, Lifeline Curve
Figure 29 North America Whole Exome Sequencing Market: By Distribution Channel, 2022
Figure 30 North America Whole Exome Sequencing Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 31 North America Whole Exome Sequencing Market: By Distribution Channel, Cagr (2023-2030)
Figure 32 North America Whole Exome Sequencing Market: By Distribution Channel, Lifeline Curve
Figure 33 North America Whole Exome Sequencing Market: Snapshot (2022)
Figure 34 North America Whole Exome Sequencing Market: By Country (2022)
Figure 35 North America Whole Exome Sequencing Market: By Country (2023 & 2030)
Figure 36 North America Whole Exome Sequencing Market: By Country (2022 & 2030)
Figure 37 North America Whole Exome Sequencing Market: By Component (2023-2030)
Figure 38 North America Whole Exome Sequencing Market: Company Share 2022 (%)